PEN logo

Penumbra, Inc. (PEN)

Profile

Full Name

Penumbra, Inc.

Ticker

NYSE: PEN

Exchange

NYSE

Sector

Healthcare

Industry

Medical Devices

Country

United States

IPO

September 18, 2015

Indexes

Not included

Website

http://www.penumbrainc.com

Employees

4500

Key Details

Price

$237.94(-2.43%)

Market cap

$9.21B(Mid cap)

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$1.19B(+12.86% YoY)

Annual EPS

$0.36(-84.48% YoY)

PE ratio

224.47

Next earnings date

Jul 29, 2025

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $237.94
    PEN price is $237.94

    30-Day Relative Volume

    0.74
    PEN 30-day relative volume is 0.74

    Price Performance

    Price Most recent change

    -2.43%
    PEN price was down -2.43% on Jul 11, 2025

    Price YTD change

    +0.19%
    PEN price is up +0.19% since January 1st

    Price 1-year change

    +27.73%
    PEN price is up +27.73% year-on-year

    Price 3-year change

    +82.4%
    PEN price is up +82.4% over the past 3 years

    Price Range

    Price All-time high

    $348.67
    PEN price is currently -31.76% below its historical high of $348.67

    Price 3-year low

    $118.65
    PEN price is currently +100.54% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market cap

    $9.21B
    PEN market capitalization is $9.21 billion

    Market cap 3-year change

    +86.47%
    PEN market capitalization is up +86.47% over the past 3 years

    Market cap All-time high

    $13.21B
    PEN market capitalization is currently -30.27% below its historical high of $13.21 billion

    Market cap sector rank

    91.98%
    PEN market capitalization is higher than 91.98% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    -0.28%
    PEN shares outstanding is down -0.28% year-on-year

    Shares Outstanding 3-Year Change

    +2.23%
    PEN shares outstanding is up +2.23% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    0.66
    PEN beta is 0.66

    200-day SMA

    $253.91
    PEN price is currently -6.29% below its 200-day simple moving average

    50-day SMA

    $266.27
    PEN price is currently -10.64% below its 50-day simple moving average

    RSI

    25.76
    PEN 14-day relative strength index is 25.76

    Volume

    0.74
    PEN 30-day relative volume is 0.74

    ATR

    $6.33
    PEN average true range is $6.33

    10-day Historical Volatility

    18.46%
    PEN 10-day historical volatility is 18.46%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $1.19B
    PEN annual revenue is $1.19 billion

    Revenue Analysts estimate

    $1.35B
    PEN annual revenue is currently -11.80% lower than the consensus analysts' forecast

    Revenue 1-year change

    +12.86%
    PEN annual revenue is up +12.86% year-on-year

    Revenue Sector rank

    81.44%
    PEN annual revenue is higher than 81.44% of companies in Healthcare sector

    EPS

    EPS

    $0.36
    PEN annual earnings per share is $0.36

    EPS Analysts estimate

    $3.75
    PEN annual earnings per share is currently -90.41% lower than the consensus analysts' forecast

    EPS 1-year change

    -84.48%
    PEN annual earnings per share is down -84.48% year-on-year

    EPS Sector rank

    85.94%
    PEN annual earnings per share is higher than 85.94% of companies in Healthcare sector

    Profit

    Gross profit

    $755.00M
    PEN annual gross profit is $755.00 million

    Gross margin

    63.20%
    PEN annual gross profit margin is 63.20%

    Operating profit

    $86.22M
    PEN annual operating income is $86.22 million

    Operating margin

    7.22%
    PEN annual operating profit margin is 7.22%

    Net income

    $14.01M
    PEN annual net profit is $14.01 million

    Net margin

    1.17%
    PEN annual net profit margin is 1.17%

    Expenses

    Total expenses

    $1.11B
    PEN annual total expenses is $1.11 billion

    Operating expenses

    $668.77M
    PEN annual total operating expenses is $668.77 million

    Cost of goods sold

    $439.62M
    PEN annual cost of goods sold is $439.62 million

    Selling, general & administrative expenses

    $573.99M
    PEN annual SGA is $573.99 million

    Depreciation and amortization

    $23.70M
    PEN annual depreciation & amortization is $23.70 million

    Interest expense

    $1.42M
    PEN annual interest expense is $1.42 million

    Income tax

    $6.86M
    PEN annual income tax is $6.86 million

    EBIT & EBITDA

    EBIT

    $22.29M
    PEN annual earnings before interest & taxes is $22.29 million

    EBITDA

    $45.99M
    PEN annual EBITDA is $45.99 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total assets

    $1.53B
    PEN annual total assets is $1.53 billion

    Non current assets

    $582.06M
    PEN annual long term assets is $582.06 million

    Current assets

    $951.13M
    PEN annual total current assets is $951.13 million

    Cash and cash equivalents

    $324.40M
    PEN annual cash & cash equivalents is $324.40 million

    Accounts receivable

    $167.67M
    PEN annual accounts receivable is $167.67 million

    Inventory

    $406.74M
    PEN annual inventory is $406.74 million

    Liabilities

    Total liabilities

    $382.25M
    PEN annual total liabilities is $382.25 million

    Long term liabilities

    $223.91M
    PEN annual total long term liabilities is $223.91 million

    Current liabilities

    $158.34M
    PEN annual total current liabilities is $158.34 million

    Accounts payable

    $31.33M
    PEN annual accounts payable is $31.33 million

    Debt

    Total debt

    $223.39M
    PEN annual total debt is $223.39 million

    Total debt 1-year change

    -4.67%
    PEN annual total debt is down -4.67% year-on-year

    Long term debt

    $208.80M
    PEN annual long term debt is $208.80 million

    Short term debt

    $14.59M
    PEN annual short term debt is $14.59 million

    Equity & Capital

    Shareholders equity

    $1.15B
    PEN annual stockholders equity is $1.15 billion

    Book value

    $1.15B
    PEN annual book value is $1.15 billion

    Retained earnings

    $60.00M
    PEN annual retained earnings is $60.00 million

    Working capital

    $792.78M
    PEN annual working capital is $792.78 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash from operations

    $168.48M
    PEN annual cash flow from operations is $168.48 million

    Cash from operations 1-year change

    +73.1%
    PEN annual cash flow from operations is up +73.1% year-on-year

    Cash from investing

    $77.62M
    PEN annual cash flow from investing activities is $77.62 million

    Cash from investing 1-year change

    +582.86%
    PEN annual cash flow from investing activities is up +582.86% year-on-year

    Cash from financing

    -$87.01M
    PEN annual cash flow from financing activities is -$87.01 million

    Cash from financing 1-year change

    -636.97%
    PEN annual cash flow from financing activities is down -636.97% year-on-year

    CAPEX

    CAPEX

    $21.18M
    PEN annual capital expenditures is $21.18 million

    CAPEX 1-year change

    +39.24%
    PEN annual capital expenditures is up +39.24% year-on-year

    Free Cash Flow

    Free cash flow

    $147.30M
    PEN annual free cash flow is $147.30 million

    Free cash flow 1-year change

    +79.37%
    PEN annual free cash flow is up +79.37% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross margin

    63.20%
    PEN annual gross profit margin is 63.20%

    Operating margin

    7.22%
    PEN annual operating profit margin is 7.22%

    Net margin

    1.17%
    PEN annual net profit margin is 1.17%

    ROA & ROE

    ROA

    0.91%
    PEN annual return on assets is 0.91%

    ROE

    1.20%
    PEN annual return on equity is 1.20%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE ratio

    224.47
    PEN price to earnings ratio is 224.47

    PE ratio Sector rank

    97.65%
    PEN price to earnings ratio is higher than 97.65% of companies in Healthcare sector

    PB Ratio

    PB ratio

    7.60
    PEN price to book ratio is 7.60

    PB ratio Sector rank

    86.1%
    PEN price to book ratio is higher than 86.1% of companies in Healthcare sector

    PS Ratio

    PS ratio

    7.43
    PEN price to sales ratio is 7.43

    PS ratio Sector rank

    72.65%
    PEN price to sales ratio is higher than 72.65% of companies in Healthcare sector

    Enterprise value

    Enterprise value

    $9.06B
    PEN enterprise value is $9.06 billion

    Enterprise value Sector rank

    91.08%
    PEN enterprise value is higher than 91.08% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    124.71
    PEN EV/EBITDA is 124.71

    EV/EBITDA Sector rank

    98.94%
    PEN EV/EBITDA is higher than 98.94% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current ratio

    6.01
    PEN annual current ratio is 6.01

    Quick ratio

    3.44
    PEN annual quick ratio is 3.44

    Leverage

    Debt to equity

    0.00
    PEN annual debt to equity ratio is 0.00

    Interest coverage ratio

    15.72
    PEN annual interest coverage ratio is 15.72

    Risk & Stability

    Piotroski F-Score

    9
    PEN piotroski f-score is 9

    Altman Z-Score

    15.97
    PEN altman z-score is 15.97

    Analyst ratings

    Recent major analysts updates

    Apr 24, 25 Wells Fargo
    Overweight
    Apr 24, 25 UBS
    Buy
    Apr 24, 25 Truist Securities
    Buy
    Apr 24, 25 Stifel
    Buy
    Apr 24, 25 RBC Capital
    Outperform
    Apr 24, 25 Baird
    Outperform
    Apr 11, 25 Truist Securities
    Buy
    Mar 14, 25 B of A Securities
    Buy
    Feb 19, 25 Wells Fargo
    Overweight
    Feb 19, 25 UBS
    Buy

    Institutional Ownership

    Screeners with PEN included

    Mid cap stocks
    US stocks
    High Piotroski score stocks
    Stocks below SMA 200
    Most recommended stocks
    Best performing stocks last 5 years
    Stocks above SMA 50
    Stocks below analysts price target
    Healthcare sector
    All stocks
    • What is the ticker symbol for Penumbra, Inc.?
    • Does Penumbra, Inc. pay dividends?
    • What sector is Penumbra, Inc. in?
    • What industry is Penumbra, Inc. in?
    • What country is Penumbra, Inc. based in?
    • When did Penumbra, Inc. go public?
    • Is Penumbra, Inc. in the S&P 500?
    • Is Penumbra, Inc. in the NASDAQ 100?
    • Is Penumbra, Inc. in the Dow Jones?
    • When was Penumbra, Inc.'s last earnings report?
    • When does Penumbra, Inc. report earnings?

    What is the ticker symbol for Penumbra, Inc.?

    The ticker symbol for Penumbra, Inc. is NYSE:PEN

    Does Penumbra, Inc. pay dividends?

    No, Penumbra, Inc. does not pay dividends

    What sector is Penumbra, Inc. in?

    Penumbra, Inc. is in the Healthcare sector

    What industry is Penumbra, Inc. in?

    Penumbra, Inc. is in the Medical Devices industry

    What country is Penumbra, Inc. based in?

    Penumbra, Inc. is headquartered in United States

    When did Penumbra, Inc. go public?

    Penumbra, Inc.'s initial public offering (IPO) was on September 18, 2015

    Is Penumbra, Inc. in the S&P 500?

    No, Penumbra, Inc. is not included in the S&P 500 index

    Is Penumbra, Inc. in the NASDAQ 100?

    No, Penumbra, Inc. is not included in the NASDAQ 100 index

    Is Penumbra, Inc. in the Dow Jones?

    No, Penumbra, Inc. is not included in the Dow Jones index

    When was Penumbra, Inc.'s last earnings report?

    Penumbra, Inc.'s most recent earnings report was on April 23, 2025

    When does Penumbra, Inc. report earnings?

    The next expected earnings date for Penumbra, Inc. is July 29, 2025
    On this page